Copyright Reports & Markets. All rights reserved.

Global Respiratory Disease Testing Market Insights, Forecast to 2025

Request for Sample of this report
Buy now
  • 1.1 Research Scope
  • 1.2 Market Segmentation
  • 1.3 Research Objectives
  • 1.4 Research Methodology
    • 1.4.1 Research Process
    • 1.4.2 Data Triangulation
    • 1.4.3 Research Approach
    • 1.4.4 Base Year
  • 1.5 Coronavirus Disease 2019 (Covid-19) Impact Will Have a Severe Impact on Global Growth
    • 1.5.1 Covid-19 Impact: Global GDP Growth, 2019, 2020 and 2021 Projections
    • 1.5.2 Covid-19 Impact: Commodity Prices Indices
    • 1.5.3 Covid-19 Impact: Global Major Government Policy
  • 1.6 The Covid-19 Impact on Respiratory Disease Testing Industry
  • 1.7 COVID-19 Impact: Respiratory Disease Testing Market Trends

    • 2 Global Respiratory Disease Testing Quarterly Market Size Analysis

    • 2.1 Respiratory Disease Testing Business Impact Assessment - COVID-19
      • 2.1.1 Global Respiratory Disease Testing Market Size, Pre-COVID-19 and Post- COVID-19 Comparison, 2015-2026
      • 2.1.2 Global Respiratory Disease Testing Price, Pre-COVID-19 and Post- COVID-19 Comparison, 2015-2026
    • 2.2 Global Respiratory Disease Testing Quarterly Market Size 2020-2021
    • 2.3 COVID-19-Driven Market Dynamics and Factor Analysis
      • 2.3.1 Drivers
      • 2.3.2 Restraints
      • 2.3.3 Opportunities
      • 2.3.4 Challenges

    3 Quarterly Competitive Assessment, 2020

    • 3.1 Global Respiratory Disease Testing Quarterly Market Size by Manufacturers, 2019 VS 2020
    • 3.2 Global Respiratory Disease Testing Factory Price by Manufacturers
    • 3.3 Location of Key Manufacturers Respiratory Disease Testing Manufacturing Factories and Area Served
    • 3.4 Date of Key Manufacturers Enter into Respiratory Disease Testing Market
    • 3.5 Key Manufacturers Respiratory Disease Testing Product Offered
    • 3.6 Mergers & Acquisitions, Expansion Plans

    4 Impact of Covid-19 on Respiratory Disease Testing Segments, By Type

    • 4.1 Introduction
      • 1.4.1 Imaging test
      • 1.4.2 Respiratory Measurement
      • 1.4.3 Blood gas test
      • 1.4.4 Other
    • 4.2 By Type, Global Respiratory Disease Testing Market Size, 2019-2021
      • 4.2.1 By Type, Global Respiratory Disease Testing Market Size by Type, 2020-2021
      • 4.2.2 By Type, Global Respiratory Disease Testing Price, 2020-2021

    5 Impact of Covid-19 on Respiratory Disease Testing Segments, By Application

    • 5.1 Overview
      • 5.5.1 Hospitals
      • 5.5.2 Physician clinics
      • 5.5.3 Clinical laboratories
      • 5.5.4 Others
    • 5.2 By Application, Global Respiratory Disease Testing Market Size, 2019-2021
      • 5.2.1 By Application, Global Respiratory Disease Testing Market Size by Application, 2019-2021
      • 5.2.2 By Application, Global Respiratory Disease Testing Price, 2020-2021

    6 Geographic Analysis

    • 6.1 Introduction
    • 6.2 North America
      • 6.2.1 Macroeconomic Indicators of US
      • 6.2.2 US
      • 6.2.3 Canada
    • 6.3 Europe
      • 6.3.1 Macroeconomic Indicators of Europe
      • 6.3.2 Germany
      • 6.3.3 France
      • 6.3.4 UK
      • 6.3.5 Italy
    • 6.4 Asia-Pacific
      • 6.4.1 Macroeconomic Indicators of Asia-Pacific
      • 6.4.2 China
      • 6.4.3 Japan
      • 6.4.4 South Korea
      • 6.4.5 India
      • 6.4.6 ASEAN
    • 6.5 Rest of World
      • 6.5.1 Latin America
      • 6.5.2 Middle East and Africa

    7 Company Profiles

    • 7.1 Fischer & Paykel
      • 7.1.1 Fischer & Paykel Business Overview
      • 7.1.2 Fischer & Paykel Respiratory Disease Testing Quarterly Production and Revenue, 2020
      • 7.1.3 Fischer & Paykel Respiratory Disease Testing Product Introduction
      • 7.1.4 Fischer & Paykel Response to COVID-19 and Related Developments
    • 7.2 Medtronic
      • 7.2.1 Medtronic Business Overview
      • 7.2.2 Medtronic Respiratory Disease Testing Quarterly Production and Revenue, 2020
      • 7.2.3 Medtronic Respiratory Disease Testing Product Introduction
      • 7.2.4 Medtronic Response to COVID-19 and Related Developments
    • 7.3 MGC Diagnostics Corporation
      • 7.3.1 MGC Diagnostics Corporation Business Overview
      • 7.3.2 MGC Diagnostics Corporation Respiratory Disease Testing Quarterly Production and Revenue, 2020
      • 7.3.3 MGC Diagnostics Corporation Respiratory Disease Testing Product Introduction
      • 7.3.4 MGC Diagnostics Corporation Response to COVID-19 and Related Developments
    • 7.4 CAREstream Medical Ltd.
      • 7.4.1 CAREstream Medical Ltd. Business Overview
      • 7.4.2 CAREstream Medical Ltd. Respiratory Disease Testing Quarterly Production and Revenue, 2020
      • 7.4.3 CAREstream Medical Ltd. Respiratory Disease Testing Product Introduction
      • 7.4.4 CAREstream Medical Ltd. Response to COVID-19 and Related Developments
    • 7.5 Becton Dickinson (Carefusion Corporation)
      • 7.5.1 Becton Dickinson (Carefusion Corporation) Business Overview
      • 7.5.2 Becton Dickinson (Carefusion Corporation) Respiratory Disease Testing Quarterly Production and Revenue, 2020
      • 7.5.3 Becton Dickinson (Carefusion Corporation) Respiratory Disease Testing Product Introduction
      • 7.5.4 Becton Dickinson (Carefusion Corporation) Response to COVID-19 and Related Developments
    • 7.6 Koninklijke Philips N.V. (Respironics)
      • 7.6.1 Koninklijke Philips N.V. (Respironics) Business Overview
      • 7.6.2 Koninklijke Philips N.V. (Respironics) Respiratory Disease Testing Quarterly Production and Revenue, 2020
      • 7.6.3 Koninklijke Philips N.V. (Respironics) Respiratory Disease Testing Product Introduction
      • 7.6.4 Koninklijke Philips N.V. (Respironics) Response to COVID-19 and Related Developments
    • 7.7 ResMed Company
      • 7.7.1 ResMed Company Business Overview
      • 7.7.2 ResMed Company Respiratory Disease Testing Quarterly Production and Revenue, 2020
      • 7.7.3 ResMed Company Respiratory Disease Testing Product Introduction
      • 7.7.4 ResMed Company Response to COVID-19 and Related Developments

    8 Supply Chain and Sales Channels Analysis

    • 8.1 Respiratory Disease Testing Supply Chain Analysis
      • 8.1.1 Respiratory Disease Testing Supply Chain Analysis
      • 8.1.2 Covid-19 Impact on Respiratory Disease Testing Supply Chain
    • 8.2 Distribution Channels Analysis
      • 8.2.1 Respiratory Disease Testing Distribution Channels
      • 8.2.2 Covid-19 Impact on Respiratory Disease Testing Distribution Channels
      • 8.2.3 Respiratory Disease Testing Distributors
    • 8.3 Respiratory Disease Testing Customers

    9 Key Findings

      10 Appendix

      • 10.1 About Us

      This report covers market size and forecasts of Respiratory Disease Testing, including the following market information:
      Global Respiratory Disease Testing Market Size, 2019-2021, and 2020 (quarterly data), (US$ Million) & (K Units)
      Global Respiratory Disease Testing Market Size by Type and by Application, 2019-2021, and 2020 (quarterly data), (US$ Million) & (K Units)
      Global Respiratory Disease Testing Market Size by Region (and Key Countries), 2019-2021, and 2020 (quarterly data), (US$ Million) & (K Units)
      Global Respiratory Disease Testing Market Size by Company, 2019- 2020 (quarterly data), (US$ Million) & (K Units)

      Key market players
      Major competitors identified in this market include Fischer & Paykel, Medtronic, MGC Diagnostics Corporation, CAREstream Medical Ltd., Becton Dickinson (Carefusion Corporation), Koninklijke Philips N.V. (Respironics), ResMed Company, etc.

      Based on the Region:
      Asia-Pacific (China, Japan, South Korea, India and ASEAN)
      North America (US and Canada)
      Europe (Germany, France, UK and Italy)
      Rest of World (Latin America, Middle East & Africa)

      Based on the Type:
      Imaging test
      Respiratory Measurement
      Blood gas test
      Other

      Based on the Application:
      Hospitals
      Physician clinics
      Clinical laboratories
      Others

      Buy now